Background: Hearing loss causes a significant reduction in the quality of life of patients with Ménière's disease. Although speech recognition is also affected, it has not been extensively studied. The objective of the study was to describe speech recognition behavior during a prolonged period in patients with unilateral Ménière's disease. Methods: A prospective case-control study was performed. The case group included patients with defined unilateral Ménière's disease and the control group included patients with progressive non-fluctuating hearing loss. Patients underwent an auditory evaluation periodically. Pure-tone audiometry and speech recognition tests-speech recognition threshold and speech discrimination score-were administered. The dissociation between pure-tone audiometry and speech recognition was assessed through a linear regression analysis. During follow-up, Ménière's disease patients were subdivided into a stable and fluctuating subgroup (a change of >20% in the speech discrimination score with a change no greater than 15 dB in pure-tone audiometry). Results: The average follow-up time was 79.9 months. Fifty-seven patients were included (30 cases, 27 controls). Dissociation between puretone audiometry and speech recognition threshold began to appear in the case group after 21 months, and it was statistically significant at 108 months. Duration of the disease was the only variable studied that influenced the dissociation. The fluctuation subgroup in cluded 56.6% of the cases. Conclusion: We described 2 audiological peculiarities in Ménière's disease patients: dissociation between pure-tone audiometry and speech recognition during the evolution of the disease and the fluctuation of speech recognition regardless of the change in pure-tone audiometry. Our results highlight the importance of performing speech recognition tests during follow-up in patients with Ménière's disease.

The study aim was to determine the benefit of cochlear implantation and hearing aids in older adults diagnosed with hearing loss and to evaluate the index of depression, anxiety and quality of life after such treatments. A retrospective cohort comprised 117 patients older than 65 years and diagnosed with moderate to profound hearing loss who were included and classified into 2 groups (treated vs. non-treated). A battery of tests including auditory (pure-tone average, disyllabic words in quiet at 65 dB SPL) and findings from a series of questions relevant to quality of life were compared between both groups. Auditory outcomes for disyllabic words were 58.21% for the cochlear implant-treated group and 82.8% for the hearing aid-treated group. There was a positive effect on anxiety, depression, health status and quality of life in the cochlear implant group versus the profound hearing loss control group. We conclude that older adults with moderate to profound hearing loss gain benefit from hearing aids or cochlear implants not only in terms of improved hearing function, but also in terms of positive effects on anxiety, depression, health status and quality of life.

Objective: Quantify the improvement and impact of the active middle ear implants (AMEIs) on a moderate-to-severe mixed hearing loss population. Study Design: Retrospective study on the indications and results obtained by individuals implanted with the AMEI. SettingS: Tertiary referral center. Patients: Thirteen adult patients with moderate-to-severe hearing loss were evaluated. Air and bone conductive pure tone audiometry and disyllabic word discrimination was performed before and after surgery. The follow-up period was from 5 to 64 months. INTERVENTION: Surgical implantation of the AMEI. MAIN OUTCOME MEASUREMENT: Auditory performance analyzed using pure tone and speech audiometry with AMEI off and on. Results: The average auditory gain in the frequency range 0.5 of 6 kHz was 44.07 dB. The average AC audiometric performance after activating the device is significantly better than the preoperative BC performance in 10 of 13 patients, with an average gain of 11.3 dB. Speech audiometry performance using disyllabic words showed a significant improvement. The detection threshold reduced significantly, from 65 to 24 dB (p = 0.012) with the AMEI. The speech recognition score at 65 dB SPL also showed a significant improvement from 28% to 90% post surgery (p = 0.004). The maximum speech recognition score also improved post surgery, from 56% to 93% with the AMEI (p = 0.023). Conclusion: The AMEI is considered an appropriate device to be used by patients with BC losses up to 70 dB, provided that hearing levels are present in all frequencies between 0.5 and 4 KHz, and the speech recognition percentage is above 60% in the ear chosen for implantation.